Literature DB >> 1479017

CA 125 concentrations in ovarian 'chocolate' cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum.

P R Koninckx1, M Muyldermans, P Moerman, C Meuleman, J Deprest, F Cornillie.   

Abstract

In a prospective study, the concentrations of CA 125, 17 beta-oestradiol and progesterone were assayed in 52 consecutive ovarian cysts, laparoscopically suspected to be endometriomas. Cysts with dark brown 'chocolate' fluid (n = 42) were excised by CO2-laser endoscopy. Cysts with clear fluid were diagnosed by pathology as follicular cysts (n = 5) or pseudoperitoneal cysts (n = 5). Fluids (n = 53) aspirated during echo-guided puncture for in-vitro fertilization (IVF) were assayed simultaneously. Of the 42 women undergoing a cystectomy, the clinical diagnosis of an endometrioma was confirmed by pathology in only 68%, the other cases being corpora lutea (27%) or follicular cysts (5%). Cyst fluids from corpora lutea had lower CA 125 concentrations (< 1000 IU/ml) together with high 17 beta-oestradiol concentrations (> 2000 pg/ml) and/or high progesterone concentrations (> 100 ng/ml). Endometriotic cysts had either very high CA 125 concentrations (> 10,000 IU/ml) as occurred in 78% or lower CA 125 concentrations (< 1000 IU/ml) together with low 17 beta-oestradiol and/or progesterone concentrations. 'Chocolate' fluid-containing cysts aspirated during IVF had similar concentration profiles of CA 125, 17 beta-oestradiol and progesterone and the diagnoses derived from these concentrations were not contradicted in 19/27 women undergoing a laparoscopy within 4 months. In eight women, however, with high CA 125 concentrations in their cyst fluid, no endometriotic cysts were found at laparoscopy. Only 68% of cysts containing 'chocolate' material were endometriotic cysts and CA 125 could be useful in making this diagnosis. This method is recommended when dark brown fluid is aspirated in IVF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479017     DOI: 10.1093/oxfordjournals.humrep.a137847

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation.

Authors:  Hsin-Yi Ho; Robert Kuo-Kuang Lee; Yuh-Ming Hwu; Ming-Huei Lin; Jin-Tsung Su; Yi-Chun Tsai
Journal:  J Assist Reprod Genet       Date:  2002-11       Impact factor: 3.412

2.  Effects of endometriomas on ooccyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study.

Authors:  E H Yanushpolsky; C L Best; K V Jackson; R N Clarke; R L Barbieri; M D Hornstein
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

3.  Management of pregnancy in woman with suspected malignant deep infiltrating endometriosis fistulised to the uterine cervix.

Authors:  Frederic Richard; Geoffroy Canlorbe; Marc Bazot; Emile Daraï
Journal:  BMJ Case Rep       Date:  2014-06-04

4.  Ovarian endometriomas do not adversely affect pregnancy success following treatment with in vitro fertilization.

Authors:  J D Isaacs; R S Hines; V M Sopelak; B D Cowan
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

5.  Ruptured ovarian endometrioma with an extreme rise in serum CA 125 level - A case report: Ovarian endometrioma with very high CA-125 level.

Authors:  Anju Kumari Rani; Deepa Kapoor
Journal:  Gynecol Oncol Case Rep       Date:  2012-05-19

6.  Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian malignancy? A case report.

Authors:  Sepideh Khodaverdi; Soheila Amini-Moghaddam; Fariba Almassi Nokiani; Neda Hashemi; Robabeh Mohammad Beigi
Journal:  Int J Reprod Biomed       Date:  2018-06

7.  Elevated CA 125 in a CASE of Leaking Endometrioma.

Authors:  Svetha Rao; Supuni Kapurubandara; Anbu Anpalagan
Journal:  Case Rep Obstet Gynecol       Date:  2018-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.